Maxigen Biotech Inc (1783) — Capital Reinvestment Ratio
Maxigen Biotech Inc (1783) has a Capital Reinvestment Ratio of 0.13x as of March 2026, meaning it reinvests 0% of its operating cash flow (NT$79.84 Million) in capital expenditures (NT$10.47 Million). See Maxigen Biotech Inc balance sheet quality to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Maxigen Biotech Inc Capital Reinvestment Ratio (2009–2025)
This chart tracks Maxigen Biotech Inc's Capital Reinvestment Ratio across 12 annual periods. Check Maxigen Biotech Inc investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Maxigen Biotech Inc (2009–2025)
Year-by-year Capital Reinvestment Ratio for Maxigen Biotech Inc from 2009 to 2025. For live market cap and broader valuation context, see market value of Maxigen Biotech Inc.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.28x | NT$290.22 Million | NT$82.63 Million | ▲ +167.3% |
| 2024 | 0.11x | NT$298.22 Million | NT$31.77 Million | ▼ -18.7% |
| 2023 | 0.13x | NT$171.20 Million | NT$22.44 Million | ▲ +143.6% |
| 2022 | 0.05x | NT$268.34 Million | NT$14.44 Million | ▼ -59.0% |
| 2021 | 0.13x | NT$117.59 Million | NT$15.45 Million | ▼ -13.8% |
| 2020 | 0.15x | NT$74.39 Million | NT$11.34 Million | ▼ -39.4% |
| 2019 | 0.25x | NT$94.42 Million | NT$23.74 Million | ▲ +112.0% |
| 2018 | 0.12x | NT$170.58 Million | NT$20.23 Million | ▼ -83.2% |
| 2017 | 0.70x | NT$41.18 Million | NT$29.01 Million | ▼ -66.4% |
| 2016 | 2.09x | NT$34.72 Million | NT$72.71 Million | ▲ +487.8% |
| 2012 | 0.36x | NT$17.53 Million | NT$6.24 Million | ▼ -9.9% |
| 2009 | 0.40x | NT$19.27 Million | NT$7.62 Million | — |